{"componentChunkName":"component---src-templates-study-details-page-js","path":"/en/study/CNA110329","result":{"data":{"studyNotFoundJson":{"title":"Study not found","content":{"childMarkdownRemark":{"html":"<p>If you entered a web address please check it was correct.</p>\n<p>You can also try <a href=\"/en/studies\">Search Page</a> to find the study you are looking for.</p>"}}},"trialDetailsJson":{"title":"Details Page","returnSearch":"Back to search results","description":"Study Description","identifier":"ViiV Study ID","clinicalID":"Clinicaltrials.gov Identifier","EudraCtID":"EudraCT Number","resultsAvailable":"Has Results Available Below","docAvailable":"Has Results Document Available","studyOverview":"Study Overview","overviewSection":{"conditionsDisplay":"Medical Conditions","product":"Product","collaborators":"Collaborators","dates":"Date","studyType":"Type","phase":"Phase","gender":"Gender","age":"Age","acceptVolunteers":"Accepts Healthy Volunteers"},"studyDocuments":"Study Documents","noDocuments":"No documents available","studyDocumentsAdditionalText":"If you wish to request for Full Study Report, please contact - ","studyDocumentsAdditionalEmail":"GSKClinicalSupportHD@gsk.com","isReleased":{"firstPart":"This study has Protocol and Result summary on ClinicalTrial.gov. Click","secondPart":"to learn more.","linkText":"here"},"mapLocations":"Locations","centralContact":"Central Contact","centralPhone":"Central Contact Phone","centralEmail":"Central Contact Email","mapSection":{"site":"GSK Investigational Site","condition":"Condition","id":"Study ID","city":"City","state":"State","zip":"Zip","country":"Country"},"studyDesign":"Study Design","designSection":{"purpose":"Primary Purpose","allocation":"Allocation","study_design":"Study Design","study_classification":"Study Classification","masking":"Masking","masked_subject":"Masked Subject","masked_caregiver":"Masked Caregiver","masked_investigator":"Masked Investigator","masked_assessor":"Masked Assessor","primary_outcomes":"Primary Outcomes","secondary_outcomes":"Secondary Outcomes","arms":"Arms","interventions":"Interventions","keyword":"Keyword","inclusionTitle":"Inclusion Criteria","exclusionTitle":"Exclusion Criteria","criteriaText":"Inclusion/Exclusion Criteria","criteria_button":"Click to view inclusion/exclusion criteria","enrollment":"Enrollment","clinicalPublications":"Clinical Publications"},"popoversText":{"studyId":{"childMarkdownRemark":{"html":"<p>A unique number for a study given by ViiV.</p>"}},"ctGov":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the US clinicaltrials.gov register. Click this link to go to the entry for this study on Clinicaltrials.gov where you will be able to see protocol and results summaries where available.</p>"}},"eudraCT":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the EU clinicaltrials.eu register. Click this link to go to the entry for this study on clinicaltrials.eu where you will be able to see protocol and results summaries where available.</p>"}}}},"site":{"siteMetadata":{"siteUrl":"https://www.viiv-studyregister.com"}},"studyDetails":{"nct_number":"NCT00481390","ctis_id":"","HasResults":"false","IpdAccessCriteria":"","IpdDescription":"","IpdInfoTypeAnalyticCode":"","IpdInfoTypeIcf":"","IpdInfoTypeCsr":"","IpdInfoTypeProtocol":"","IpdInfoTypeSap":"","IpdTimeFrame":"","IpdUrl":"","IsFlexibleTrial":false,"IsReleasedToCtGov":"true","MaskingInfo":{"masked_assessor":"","masked_caregiver":"","masked_investigator":"","masked_subject":"","masking_description":"","no_masking":""},"PatientLevelData":"false","SharingIpd":"","acronym":"","allocation":"","arm_groups":[{"arm_group_label":"HIV-1 infected adults","arm_group_description":"HIV-1 infected adults","arm_type":""}],"assignment":"","brief_summary":"This study is a cross-sectional observational study to evaluate the prevalence of HLA-B*5701 in the European area and in major European ethnotypes. Any HIV-1 infected patient will be eligible for this study including treatment naïve and experienced patients, as well as patients previously tested for HLA-B*5701. Patients will be approached during a standard clinic visit, and will be consented prior to any study specific procedure. They will be asked to provide a tissue sample (cheek cells and blood sample) which will be used to assess HLA-B*5701 status by local and central laboratories. In selected sites patients may be asked to provide an additional blood sample. This sample will be used to develop and validate different methodologies for assessing HLA-B*5701 status.","brief_summary_OneLinkTx":"","brief_title_OneLinkTx":"","brief_title":"Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients","conditions":[{"DisplayValue":"Human Immunodeficiency Virus (HIV)","DisplayValue_OneLinkTx":"","InternalValue":"CON_HIV","LookupValue":"Infection, Human Immunodeficiency Virus I","LookupValue_OneLinkTx":""}],"created_date":"09/15/2018 18:01:50","criteria":"Inclusion criteria: - HIV-1 infected patients over the age of 18 years - Patient is willing and able to understand and provide written informed consent Exclusion criteria: - None","detailed_description":"","display_gender":"Both","display_gender_internal":"GENDER_ALL","display_phase":"","display_phase_internal":"","display_status":"Finalized","display_status_internal":"RECSTATUS_O_COMPLETED","endpoint":"","enrollment":"1110","exclusion":"","gender":"Both","gender_based":"","gender_description":"","healthy_volunteers":"No","id":"1abb7bef-fab3-5b63-aac0-2f0b5ec22d8e","internal":{"content":null,"contentDigest":"ae89ca254ba058d0d06d821aa1586b9e","description":null,"fieldOwners":null,"mediaType":null,"ignoreType":null,"owner":"default-site-plugin","type":"studyDetails"},"inclusion":"Inclusion criteria: - HIV-1 infected patients over the age of 18 years - Patient is willing and able to understand and provide written informed consent Exclusion criteria: - None","interventions":[{"arm_group_label":"HIV-1 infected adults","intervention_description":"Cheek cells sample","intervention_name":"Cheek cells sample","intervention_type":"Procedure/Surgery"},{"arm_group_label":"HIV-1 infected adults","intervention_description":"Blood sample","intervention_name":"Blood sample","intervention_type":"Procedure/Surgery"}],"interventional_subtype":"","is_fda_regulated":false,"is_high_value":false,"is_ind_study":false,"keywords":["HIV","HLA-B*5701","prevalence"],"last_follow_up_date":"12/01/2007 00:00:00","links":[],"locations":[{"City":"Maastricht","Latitude":"50.8329228","CountryDisplay":"Netherlands","Longitude":"5.7120706","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"6229 HX","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Amadora","Latitude":"38.7441746","CountryDisplay":"Portugal","Longitude":"-9.246341","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"2720-276","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"DEN HAAG","Latitude":"52.0740701","CountryDisplay":"Netherlands","Longitude":"4.299593","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"2512 VA","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"AMSTERDAM","Latitude":"52.2949983","CountryDisplay":"Netherlands","Longitude":"4.9602433","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"1105 AZ","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Lausanne","Latitude":"46.5196535","CountryDisplay":"Switzerland","Longitude":"6.6322734","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"1011","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Lisboa","Latitude":"38.7222524","CountryDisplay":"Portugal","Longitude":"-9.1393366","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"1150","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Bern","Latitude":"46.9475044","CountryDisplay":"Switzerland","Longitude":"7.423628","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"3010","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"ROTTERDAM","Latitude":"51.910955","CountryDisplay":"Netherlands","Longitude":"4.4676171","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"3015 GD","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"GRONINGEN","Latitude":"53.2207562","CountryDisplay":"Netherlands","Longitude":"6.5762139","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"9713 GZ","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"DEN HAAG","Latitude":"52.0566289","CountryDisplay":"Netherlands","Longitude":"4.2666688","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"2545 CH","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Lugano","Latitude":"46.009366","CountryDisplay":"Switzerland","Longitude":"8.9507851","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"6900","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Zürich","Latitude":"47.3768866","CountryDisplay":"Switzerland","Longitude":"8.541694","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"8030","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Helsinki","Latitude":"60.1698557","CountryDisplay":"Finland","Longitude":"24.9383791","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"00029","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"La Chaux-de-Fonds","Latitude":"47.1034892","CountryDisplay":"Switzerland","Longitude":"6.8327838","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"CH 2301","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"ENSCHEDE","Latitude":"52.2193385","CountryDisplay":"Netherlands","Longitude":"6.8882789","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"7511JX","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Dublin","Latitude":"53.3478525","CountryDisplay":"Ireland","Longitude":"-6.3181152","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"8","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"ALKMAAR","Latitude":"52.6266188","CountryDisplay":"Netherlands","Longitude":"4.7361879","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"1815 JD","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Zuerich","Latitude":"47.3768866","CountryDisplay":"Switzerland","Longitude":"8.541694","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"8091","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"ROTTERDAM","Latitude":"51.89055","CountryDisplay":"Netherlands","Longitude":"4.5244438","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"3078 HT","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"ARNHEM","Latitude":"51.9997622","CountryDisplay":"Netherlands","Longitude":"5.9109539","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"6815 AD","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"}],"masking":"","maximum_age_raw":"N/A N/A","maximum_age":"N/A","minimum_age":"18","minimum_age_raw":"18 years","modified_date":"10/01/2018 23:03:35","number_of_arms":"","observational_design":{"biospecimen_description":"","biospecimen_retention":"Samples With DNA","number_of_groups":"1","observational_study_design":"Cohort","patient_registry":"","target_duration_quantity":"","target_duration_units":"","timing":"Prospective"},"official_title":"Prospective epidemiological study of the prevalence of HLA-B*5701 in HIV-1 infected patients","org_study_id":"CNA110329","overall_contact":{"email":null,"last_name":"US GSK Clinical Trials Call Center","phone":"877-379-3718"},"overall_status":"Completed - Observational","oversight_info":{"exported_from_us":"","fda_regulated_device":"","fda_regulated_drug":"","ped_postmarket_surv":"","has_dmc":null,"post_prior_to_approval":"","regulatory_authorities":[""]},"phase":"","primary_compl_date":"12/01/2007 00:00:00","primary_outcomes":[{"outcome_description":"","outcome_measure":"Prevalence of HLA-B*5701 in European HIV-1 population","outcome_time_frame":"n/a","outcome_safety_issue":null}],"product_name":"","product_name_OneLinkTx":"","secondary_ids":[],"secondary_outcomes":[{"outcome_description":"","outcome_measure":"Prevalence of HLA-B*5701 in major European ethnotypes","outcome_time_frame":"n/a","outcome_safety_issue":null}],"sponsors":{"investigator_affiliation":"","investigator_username":"","lead_sponsor":"ViiV Healthcare","collaborators":[]},"start_date":"06/01/2007 00:00:00","study_type":"Observational","therapeutic_area":"Infectious Diseases","citations":[],"is_section_801":null}},"pageContext":{"studyId":"CNA110329"}},"staticQueryHashes":["162689979","3332233851","3729204765","3769354840","399703114"]}